Skip to main content

PRPH

ProPhase Labs, Inc.

Company with tickers: PRPH

CIK
868278
CUSIP
74345W207
Shares Outstanding
14,016,025
Investor Relations
https://ir.prophaselabs.com/
13F Activity (30d)
1 filings 1 filers

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Line Item Value
Revenue —
Revenue (ASC 606) $4,345,000
Cost of Revenue —
Gross Profit $1,384,000
Operating Expenses $19,431,000
Research & Development $107,000
Operating Income $-18,047,000
Net Income $-14,743,000
EPS (Basic) $-1.74
EPS (Diluted) $-1.74

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

By Segment (USD)

Component 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Consumer Products — $10,483,000 $14,318,000 $10,135,000 $6,770,000 $4,345,000
Diagnostic Services — $68,559,000 $108,329,000 $24,849,000 $0 $0
Consumer Products $13,237,000 — — — — —
Diagnostic Services $1,277,000 — — — — —